Skip to main content
Erschienen in: Infection 5/2016

09.05.2016 | Case Report

Analysis of peritoneal galactomannan for the diagnosis of Aspergillus peritonitis

verfasst von: Karl Dichtl, Johannes Wagener, Johannes Tschöp, Ludwig Ney

Erschienen in: Infection | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Here, we report a patient developing a postoperative peritoneal infection by Aspergillus fumigatus. While galactomannan serum levels were negative throughout the time course, galactomannan levels in peritoneal fluids yielded high results. Serological testing of peritoneal fluids for fungal antigens might be a useful and easily applicable tool to support diagnosis of intraabdominal aspergillosis, which represents a rare type of invasive fungal infection.
Literatur
1.
2.
Zurück zum Zitat Brodská H, et al. Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Clin Exp Med. 2013;13:165–70.CrossRefPubMed Brodská H, et al. Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Clin Exp Med. 2013;13:165–70.CrossRefPubMed
3.
Zurück zum Zitat Marková M, et al. Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients. Support Care Cancer. 2013;21:2733–42.CrossRefPubMed Marková M, et al. Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients. Support Care Cancer. 2013;21:2733–42.CrossRefPubMed
4.
Zurück zum Zitat Lichtenstern C, et al. Relevance of Candida and other mycoses for morbidity and mortality in severe sepsis and septic shock due to peritonitis. Mycoses. 2015;58:399–407.CrossRefPubMed Lichtenstern C, et al. Relevance of Candida and other mycoses for morbidity and mortality in severe sepsis and septic shock due to peritonitis. Mycoses. 2015;58:399–407.CrossRefPubMed
5.
Zurück zum Zitat Imola M, et al. Emergency emicolectomy for intestinal primary Aspergillosis in acute myeloid leukemia. G Chir. 2012;33:74–6.PubMed Imola M, et al. Emergency emicolectomy for intestinal primary Aspergillosis in acute myeloid leukemia. G Chir. 2012;33:74–6.PubMed
6.
Zurück zum Zitat Kazan E, et al. A retrospective series of gut aspergillosis in haematology patients. Clin Microbiol Infect. 2011;17:588–94.CrossRefPubMed Kazan E, et al. A retrospective series of gut aspergillosis in haematology patients. Clin Microbiol Infect. 2011;17:588–94.CrossRefPubMed
7.
Zurück zum Zitat Lehrnbecher T, et al. Primary intestinal aspergillosis after high-dose chemotherapy and autologous stem cell rescue. Pediatr Infect Dis J. 2006;25:465–6.CrossRefPubMed Lehrnbecher T, et al. Primary intestinal aspergillosis after high-dose chemotherapy and autologous stem cell rescue. Pediatr Infect Dis J. 2006;25:465–6.CrossRefPubMed
8.
Zurück zum Zitat Mohite U, et al. Invasive aspergillosis localised to the colon presenting as toxic megacolon. Eur J Haematol. 2007;78:270–3.CrossRefPubMed Mohite U, et al. Invasive aspergillosis localised to the colon presenting as toxic megacolon. Eur J Haematol. 2007;78:270–3.CrossRefPubMed
9.
Zurück zum Zitat Karaman I, Karaman A, Boduroğlu EC, Erdoğan D, Tanır G. Invasive Aspergillus infection localized to the gastric wall: report of a case. Surg Today. 2012;43:682–4.CrossRefPubMed Karaman I, Karaman A, Boduroğlu EC, Erdoğan D, Tanır G. Invasive Aspergillus infection localized to the gastric wall: report of a case. Surg Today. 2012;43:682–4.CrossRefPubMed
10.
Zurück zum Zitat Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect. 2006;12:1060–76.CrossRefPubMed Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect. 2006;12:1060–76.CrossRefPubMed
11.
Zurück zum Zitat Jensen J, et al. Post-surgical invasive aspergillosis: an uncommon and under-appreciated entity. J Infect. 2010;60:162–7.CrossRefPubMed Jensen J, et al. Post-surgical invasive aspergillosis: an uncommon and under-appreciated entity. J Infect. 2010;60:162–7.CrossRefPubMed
12.
Zurück zum Zitat De Pauw B, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;46:1813–21.CrossRef De Pauw B, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;46:1813–21.CrossRef
13.
Zurück zum Zitat Maertens J, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol. 1999;37:3223–8.PubMedPubMedCentral Maertens J, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol. 1999;37:3223–8.PubMedPubMedCentral
14.
Zurück zum Zitat Ku NS, et al. Diagnostic value of the serum galactomannan assay for invasive aspergillosis: it is less useful in non-haematological patients. Scand J Infect Dis. 2012;44:600–4.CrossRefPubMed Ku NS, et al. Diagnostic value of the serum galactomannan assay for invasive aspergillosis: it is less useful in non-haematological patients. Scand J Infect Dis. 2012;44:600–4.CrossRefPubMed
15.
Zurück zum Zitat Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis. 2005;40:1762–9.CrossRefPubMed Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis. 2005;40:1762–9.CrossRefPubMed
16.
Zurück zum Zitat Bassetti M, et al. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med. 2013;39:2092–106.CrossRefPubMed Bassetti M, et al. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med. 2013;39:2092–106.CrossRefPubMed
17.
Zurück zum Zitat Ates O, et al. Diagnosis of Aspergillus niger peritonitis in a peritoneal dialysis patient by peritoneal galactomannan and β-d-glucan detection. Perit Dial Int. 2013;33:216–8.CrossRefPubMedPubMedCentral Ates O, et al. Diagnosis of Aspergillus niger peritonitis in a peritoneal dialysis patient by peritoneal galactomannan and β-d-glucan detection. Perit Dial Int. 2013;33:216–8.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Leelahavanichkul A, et al. (1 → 3)-β-d-glucan and galactomannan for differentiating chemical ‘black particles’ and fungal particles inside peritoneal dialysis tubing. Perit Dial Int J Int Soc Perit Dial. 2015. doi:10.3747/pdi.2014.00235. Leelahavanichkul A, et al. (1 → 3)-β-d-glucan and galactomannan for differentiating chemical ‘black particles’ and fungal particles inside peritoneal dialysis tubing. Perit Dial Int J Int Soc Perit Dial. 2015. doi:10.​3747/​pdi.​2014.​00235.
19.
Zurück zum Zitat Worasilchai N, et al. (1 → 3)-β-d-glucan and galactomannan testing for the diagnosis of fungal peritonitis in peritoneal dialysis patients, a pilot study. Med Mycol. 2015;53:338–46.CrossRefPubMed Worasilchai N, et al. (1 → 3)-β-d-glucan and galactomannan testing for the diagnosis of fungal peritonitis in peritoneal dialysis patients, a pilot study. Med Mycol. 2015;53:338–46.CrossRefPubMed
21.
Zurück zum Zitat Miles R, et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int. 2009;76:622–8.CrossRefPubMed Miles R, et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int. 2009;76:622–8.CrossRefPubMed
Metadaten
Titel
Analysis of peritoneal galactomannan for the diagnosis of Aspergillus peritonitis
verfasst von
Karl Dichtl
Johannes Wagener
Johannes Tschöp
Ludwig Ney
Publikationsdatum
09.05.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 5/2016
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0902-2

Weitere Artikel der Ausgabe 5/2016

Infection 5/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.